The molecular benefits of PCR in platforms testing for COVID-19 and influenza
Discover how real-time analytics of your laboratory assays can provide valuable insights through key metrics, such as test outcomes, assay performance, and laboratory proficiency monitoring, including cross-assay comparisons. As laboratories move beyond COVID testing, there are many advantages to using multiplex PCR tests in the management of respiratory tract infections.
- Examine various scenarios of diagnostics latency and care gaps, including the potential impact on patient outcome
- Analytical and practical performance difference between different platforms
- Learn more about the benefits of multiplex PCR testing
Anami Patel, Ph.D.
Chief Science Officer, Poplar Healthcare
Imran Mujawar, MBBS, MS
Sr. Staff Data Scientist, Thermo Fisher Scientific
Manoj Gandhi, M.D., Ph.D.
Senior Director of Medical and Scientific Affairs, Thermo Fisher Scientific